# XTR003 PET Radiotracer for the Detection of Viable Myocardium

> **NCT05885854** · PHASE2 · COMPLETED · sponsor: **Sinotau Pharmaceutical Group** · enrollment: 51 (actual)

## Conditions studied

- Ischemic Heart Disease (IHD)

## Interventions

- **DRUG:** XTR003

## Key facts

- **NCT ID:** NCT05885854
- **Lead sponsor:** Sinotau Pharmaceutical Group
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-12-15
- **Primary completion:** 2023-03-04
- **Final completion:** 2023-03-05
- **Target enrollment:** 51 (ACTUAL)
- **Last updated:** 2023-06-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05885854

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05885854, "XTR003 PET Radiotracer for the Detection of Viable Myocardium". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT05885854. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*